Phibro Animal Health Corporation Declares Quarterly Dividend

Core Viewpoint - Phibro Animal Health Corporation has declared a quarterly cash dividend of $0.12 per share for its Class A and Class B common stock, payable on December 17, 2025, to stockholders of record as of November 26, 2025 [1] Company Overview - Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company, aiming to be a trusted partner for livestock producers, farmers, veterinarians, and consumers by providing solutions to enhance animal health [2] Recent Developments - The company announced the national launch of Restoris™ piezoelectric dental gel for dogs, designed to support long-term oral health in dogs with periodontal disease, developed in collaboration with a leading U.S. dental school [3][5] - Phibro has entered into a licensing agreement with Lighthouse Pharmaceuticals, Inc. for a novel therapeutic asset targeting periodontal health in companion animals, granting Phibro exclusive rights to develop, manufacture, and commercialize the proprietary compound [7]